BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

3:58 PM
Sep 21, 2012
 |  BC Extra  |  Top Story

Vivus falls on expected CHMP negative opinion

Vivus Inc. (NASDAQ:VVUS) fell $2.72 (11%) to $21 on Friday after the company said it expects EMA's CHMP to issue a negative opinion next month for an MAA for obesity drug Qsiva phentermine/topiramate. Vivus President Peter Tam told BioCentury that the committee...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >